Back to top

Jazz Pharmaceuticals plc Enters Oversold Territory

Read MoreHide Full Article

Jazz Pharmaceuticals plc’s (JAZZ - Free Report) share price has entered into oversold territory with a stochastic value of 10.2848. The Zacks Consensus Estimate on the company’s earnings for December 2012 increased by 1 cent over the past month to $3.79 per share. Jazz Pharmaceuticals plc is a Zacks #2 Rank (“ Buy”) company.


In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Jazz Pharmaceuticals PLC (JAZZ) - free report >>

More from Zacks Tale of the Tape

You May Like